← Back to Search

18F-DCFPyL for Prostate Cancer

Q: Does the eligibility for this clinical trial include individuals over 25 years of age?

This clinical trial has outlined that participants must be between 18-89 years of age. If a potential participant is younger than 18, there are 76 other studies they can consider; if over 65, 1334 different trials beckon.

Q: What is the upper limit of volunteers enrolled in this research project?

Affirmative. The records on clinicaltrials.gov reveal that this investigation is currently accepting participants, having first been posted in June 8th 2018 and updated as recently as February 25th 2020. A total of 48 subjects are being recruited across 1 medical centre.

Q: Are any individuals being accepted to participate in this experiment presently?

According to information on clinicaltrials.gov, this health study is actively searching for participants. Initially posted on June 8th 2018 and last edited February 25th 2020, the trial has been ongoing since then.

Q: Is it possible for me to join this clinical experiment?

This clinical trial seeks 48 volunteers aged between 18 and 89 who are diagnosed with prostate cancer. To qualify, they must be able to comprehend the written informed consent form, have a biopsy-proven diagnosis of high risk or locally <a href="https://www.withpower.com/clinical-trials/advanced-prostate-cancer">advanced prostate cancer</a> that meets NCCN Guidelines (T3-T4 disease), demonstrate an ECOG performance status of 0-2, agree to use adequate contraception during treatment and for 30 days after completion of imaging scans; and finally meet the minimum age requirement.

Q: Can you inform me of any additional experiments utilizing 18F-DCFPyL?

Currently, 18F-DCFPyL has been subject to 18 active medical trials with none in the final phase. Although a large amount of research is located within Baltimore, <a href="https://www.withpower.com/clinical-trials/maryland">Maryland</a> there are still 27 different sites carrying out investigations into this pharmaceutical compound.

Phase < 1

Waitlist Available

Led By Edward Schaeffer, MD/PhD

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 years

Awards & highlights

Study Summary

This trial will help researchers learn if PET-MR using PyL is accurate in diagnosing prostate cancer and finding out how far the cancer has spread.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PET/MR versus mp-MRI for the Staging of Newly Diagnosed Prostate Cancer

Side effects data

From 2019 Phase 3 trial • 208 Patients • NCT03739684

Headache

Fatigue

Hypertension

100%

80%

60%

40%

20%

Study treatment Arm

18F-DCFPyL Injection

Trial Design

1Treatment groups

Experimental Treatment

Group I: 18F-DCFPyLExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Piflufolastat F 18

FDA approved

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor

1,585 Previous Clinical Trials

917,183 Total Patients Enrolled

19 Trials studying Prostate Cancer

2,911 Patients Enrolled for Prostate Cancer

Progenics Pharmaceuticals, Inc.Industry Sponsor

33 Previous Clinical Trials

4,902 Total Patients Enrolled

17 Trials studying Prostate Cancer

2,286 Patients Enrolled for Prostate Cancer

Edward Schaeffer, MD/PhDPrincipal Investigator - Chair, Department of Urology

Northwestern Lake Forest Hospital, Northwestern Memorial Hospital

University Of Chicago (Medical School)

Johns Hopkins University School Medicine (Residency)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility for this clinical trial include individuals over 25 years of age?

"This clinical trial has outlined that participants must be between 18-89 years of age. If a potential participant is younger than 18, there are 76 other studies they can consider; if over 65, 1334 different trials beckon."

Answered by AI

What is the upper limit of volunteers enrolled in this research project?

"Affirmative. The records on clinicaltrials.gov reveal that this investigation is currently accepting participants, having first been posted in June 8th 2018 and updated as recently as February 25th 2020. A total of 48 subjects are being recruited across 1 medical centre."

Answered by AI

Are any individuals being accepted to participate in this experiment presently?

"According to information on clinicaltrials.gov, this health study is actively searching for participants. Initially posted on June 8th 2018 and last edited February 25th 2020, the trial has been ongoing since then."

Answered by AI

Is it possible for me to join this clinical experiment?

"This clinical trial seeks 48 volunteers aged between 18 and 89 who are diagnosed with prostate cancer. To qualify, they must be able to comprehend the written informed consent form, have a biopsy-proven diagnosis of high risk or locally advanced prostate cancer that meets NCCN Guidelines (T3-T4 disease), demonstrate an ECOG performance status of 0-2, agree to use adequate contraception during treatment and for 30 days after completion of imaging scans; and finally meet the minimum age requirement."

Answered by AI

Can you inform me of any additional experiments utilizing 18F-DCFPyL?

"Currently, 18F-DCFPyL has been subject to 18 active medical trials with none in the final phase. Although a large amount of research is located within Baltimore, Maryland there are still 27 different sites carrying out investigations into this pharmaceutical compound."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Edward Schaeffer 2018. "PET/MRI for the Staging of Newly Diagnosed Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03392181.